MedTrace Logo

Bioavailability of Vitamin D(25(OH)D) and Omega-3 Fatty Acid (DHA) Enhanced Chicken

NCT05248737 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2026-04-01

No results posted yet for this study

Summary

The purpose of the research is to evaluate if chicken or eggs obtained from chickens that are fed a diet that contains omega-3 fatty acids (DHA/EPA), or vitamin D (as 25(OH)D) provides additional health benefits by improving the status of omega-3 fatty acids or 25(OH)D in healthy adults who eat this bioenhanced chicken or eggs.

Conditions

  • Nutrition, Healthy

Interventions

DIETARY_SUPPLEMENT

DHA/EPA fortified chicken plus Placebo

For participants who received DHA/EPA fortified chicken

DIETARY_SUPPLEMENT

non-25(OH)D fortified chicken/eggs plus vitamin D3 supplement

Provided to participants in the group where they consumed non-fortified chicken/eggs

DIETARY_SUPPLEMENT

non-DHA bio-enhanced chicken plus supplement DHA Omega-3

Used in the crossover part of the study given to the group who did not received DHA bio-enhanced chicken

DIETARY_SUPPLEMENT

25(OH)D bioenhanced chicken and eggs plus placebo

participants will receive 25(OH)D bioenhanced chicken and eggs plus a placebo as a dietary intervention

DIETARY_SUPPLEMENT

Dietary Supplement: DHA/EPA fortified eggs plus Placebo

For the participants who received DHA/EPA fortified eggs

DIETARY_SUPPLEMENT

non-DHA bio-enhanced eggs plus supplement DHA Omega-3

for the participants who received non-DHA bio-enhanced eggs plus supplement DHA Omega-3

OTHER

non-25(OH)D fortified chicken/eggs plus placebo

Provided to participants in the group where they consumed non-fortified chicken/eggs + placebo pills

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-04
Primary Completion
2024-12-11
Completion
2026-05-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05248737 on ClinicalTrials.gov